title: A potential therapeutic strategy for capillary hemangioma with new anti-vascular endothelial growth factor (anti-VEGF) agents.
authors.forename: Morsal
authors.initials: M
authors.lastname: Mehriar
authors.forename: Abbas
authors.initials: A
authors.lastname: Attarzadeh
authors.forename: Mahsa
authors.initials: M
authors.lastname: Naseri
authors.forename: Naser
authors.initials: N
authors.lastname: Owji
authors.forename: Sirus
authors.initials: S
authors.lastname: Siyoofi
authors.forename: Mahnaz
authors.initials: M
authors.lastname: Mosallaei
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D018324:Hemangioma, Capillary / Q000188:drug therapy*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D040262:Receptors, Vascular Endothelial Growth Factor / Q000276:immunology; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D042461:Vascular Endothelial Growth Factor A; D040262:Receptors, Vascular Endothelial Growth Factor